Theme: If you can Detect it you can treat it

World Oncologists-2016

World Oncologists-2016

14th World Oncologists Annual Conference International Conferences invites all the participants from all over the world to attend the prestigious Scientific Conference on Cancer and its advances and Radiation Medicine  during November,28-30, 2016 in San Francisco, USA which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

Cancer

Cancer, also called malignancy, is an abnormal growth of cells. There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer treatment may include chemotherapy, radiation, and surgery.

Track 1: Pathophysiology of Cancer

The pathophysiology of cancer is not completely defined. Alterations of several molecular factors have been associated with malignancy. Cancer begins in cells of the body’s Functional system, which is made up of cells that are a cross between traditional hormone-producing endocrine cells and nerve cells. Cells are found throughout the body in organs such as the lungs and gastrointestinal tract, including the stomach and intestines. They perform specific functions, such as regulating the air and blood flow through the lungs and controlling the speed at which food is moved through the gastrointestinal tract. A risk factor is anything that increases a person’s chance of developing a Tumor. Although risk factors often influence the development of a tumor, most do not directly cause it. Some people with several risk factors never develop a tumor, while others with no known risk factors do some risk factors are as disused Age, Gender, Race/Ethnicity, Family history, Immune system suppression, Arsenic exposure. Generally, the cause of Cancer is unknown people who have one of the rare family syndromes have a higher risk of developing Tumors.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                             

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

  Track 2: Types of Cancer

There are a number of different types of Cancer. They are generally are called after the organ or type of cell they develop in Introduction, Medical Illustrations, Risk Factors, Prevention, Symptoms & Signs, Diagnosis, Stages, Treatment Options, About Clinical Trials, Latest Research, Coping with Treatment, Follow-Up Care, Survivorship, The American Society of Clinical Oncology (ASCO) believes that all treatment decisions should be made between patients and their doctors.Tumor most often develop in the gut or pancreas. These tumours are sometimes grouped together and called gastroenteropancreatic neuroendocrine tumours or GEP NETs for short. NETs of the gut are most often carcinoid tumours. They may also just be called carcinoid. NETs that develop in the pancreas are also called endocrine tumours of the pancreas. Some of these tumours can also develop outside the pancreas. For example, gastrinomas have been reported in the medical literature to develop in the ovaries, kidneys, stomach and liver, and not just in the pancreas and small bowel area. Common types of Cancer most often diagnosed are Breast Cancer, Bladder Cancer, Colorectal Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Melanoma, Oral and Oropharyngeal Cancer, Pancreatic, Prostate, Thyroid, Uterine Cancer.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                        

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; The Endocrine Society Annual Meeting April 1-4, 2016 Boston, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE

Track 3: Brain Cancer

The brain and the spinal cord make up the central nervous system (CNS) Brain and spinal cord Tumor are the growths of abnormal cells in the tissues of the brain or spinal cord. Tumor that begin in the brain are called the primary brain Tumor. Cancer that spreads to the brain from other parts of the body is called a metastatic brain Tumor this is different from a primary brain Tumor. Brain and spinal cord Tumor may be either benign (not Cancer) or malignant (cancer). Both these Tumor grow and press on the nearby areas of the brain but rarely spread into other parts of the brain. There are many different types of brain and spinal cord Tumor they form in different cell types and different areas of the brain and spinal cord. This Tumor can mainly occur in both children’s and Adults the chance of recovery depends on many factors, including age, Tumor size, Tumor type and where the Tumor is in the CNS.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                 

International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; 12th Global Summit on Cancer Therapy September 26-28, 2016 London, UK; 13th Global Summit on Cancer Therapy October 17-19, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; Advances in Medical and Surgical Management of Thyroid Cancer January 15-16, 2016; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA

 

Track 4: Skin Cancer

.Skin Cancer is the abnormal growth of skin cells. This type of Cancer is mainly caused by the exposure of the skin to the high intensity sun rays. Skin Cancer affects all types of skin coloured people and races. The most effected people are those with the light skin tone from the sunburns. There are different types of skin cancer the most commonly occurring type is Basal Cell Carcinoma (BCC) and Melanoma is the most deadliest form of skin Cancer.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                           

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

Track 5: Breast Cancer

Breast cancer can begin in different areas of the breast the ducts, the lobules, or in some cases, the tissue in between. In this section, you can learn about the different types of breast cancer, including non-invasive, invasive, recurrent, and metastatic breast cancers. You can also read about breast cancer in men. Breast tissue contains of fat and connective tissue, lymph nodes and blood vessels they are made up of glands called tubules that can make milk and thin tubes called ducts that carry the milk to the nipple. The most common type of breast Cancer is ductal Carcinoma. Breast Cancer can also begin in the cells of the lobules in other tissues in the breast.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                         

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; The Endocrine Society Annual Meeting April 1-4, 2016 Boston, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE

Track 6: Reproductive Cancer

Reproductive Cancers are those Cancers that occur in the reproductive organs of both Women and Men. In Women, these are Cancers that commonly occur in the breast, cervix, vulva, endometrium or Ovaries. In men reproductive Cancer can be found in the prostate, testicles, and penis.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                   

International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; 12th Global Summit on Cancer Therapy September 26-28, 2016 London, UK; 13th Global Summit on Cancer Therapy October 17-19, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; Advances in Medical and Surgical Management of Thyroid Cancer January 15-16, 2016; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA

Track 7: Surgical Oncology

Surgery is the main treatment in nearly every case of cancer, and it is the main treatment for both pheochromocytoma and Merkel cell cancer. During surgery, the doctor removes the tumor along with a small border of healthy tissue around the tumor, called a margin For pheochromocytoma, laparoscopic surgery may be performed. Laparoscopic surgery is a less invasive type of surgery that uses three or four small incisions instead of one large incision. A thin, lighted tube called a laparoscope that is attached to a video camera is inserted through one opening to guide the surgeon. Surgical instruments are inserted through the other openings to perform the surgery. If removing the tumor using surgery is not possible, it is called an inoperable tumor, and the doctor will recommend another type of treatment. The patient candidate for surgery or not depends on factors such as the type, size, location, grade and stage of the Tumor along with the consideration of the general health factors like age, physical fitness and other coexisting medical conditions. Surgery will be combined with other Cancer treatments, such as chemotherapy, Radiation therapy or hormone therapy in some Cases.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                             

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

Track 8 : Neuroendocrine Cancer (NETs)

There are a number of different types of NETs. They are generally called after the organ or type of cell they develop in. NETs most often develop in the gut or pancreas. These tumours are sometimes grouped together and called gastroenteropancreatic neuroendocrine tumours or GEP NETs for short. NETs of the gut are most often carcinoid tumours. They may also just be called carcinoid. NETs that develop in the pancreas are also called endocrine tumours of the pancreas. Some of these tumours can also develop outside the pancreas. For example, gastrinomas have been reported in the medical literature to develop in the ovaries, kidneys, stomach and liver, and not just in the pancreas and small bowel area.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                       

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; The Endocrine Society Annual Meeting April 1-4, 2016 Boston, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE

Track 9 : Immuno-Oncology

The immune system’s natural capacity to detect and destroy abnormal cells may prevent the development of many cancers. However, cancer cells are sometimes able to avoid detection and destruction by the immune system. Cancer cells may.The latest exciting reseach Breakthrough for cancer treatment is immune-oncology. This type of treatment enhances the patient’s own immune system to stop the growing cancer cells. This treatment is with the    T-cells these T-cells usually recognize cancer cells as being foreign and attack those cells in this treatment the drugs will suppress the PD-L1 molecule that is available on the surface of the cancer cell and that will allow the T-cell to attack that cancer cells the current research is mainly going on the Immuno-Oncology with good growth rate and treatment success.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                            

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

 

Track 10: Cancer Trends and Opportunities

Doctors and scientists are always looking for better ways to treat patients with tumor. To make scientific advances, doctors create research studies involving volunteers, called clinical trials. Many clinical trials are focused on new treatments, evaluating whether a new treatment is safe, effective, and possibly better than the current (standard) treatment. These types of studies evaluate new drugs, different combinations of existing treatments, new approaches to radiation therapy or surgery, and new methods of treatment. Patients who participate in clinical trials are often among the first to receive new treatments before they are widely available. However, there is no guarantee that the new treatment will be safe, effective, or better than a standard treatment. There are also clinical trials that study new ways to ease symptoms and side effects during treatment and managing the late effects that may occur after treatment. Talk with your doctor about clinical trials regarding side effects.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                    

International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; 12th Global Summit on Cancer Therapy September 26-28, 2016 London, UK; 13th Global Summit on Cancer Therapy October 17-19, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; Advances in Medical and Surgical Management of Thyroid Cancer January 15-16, 2016; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA

Track 11: Radiation Oncology

Radiation Medicine is a  process in wich they use high-energy radiation, in the form of waves or particles, to destroy cancer cells by damaging their DNA. Because radiation can harm healthy cells, treatment must be carefully planned and precisely conducted to minimize side effects. Radiation therapy may be given before, during, or after other therapies in your treatment plan. It may be used alone or with other treatments to destroy cancer cells, shrink tumors, prevent recurrence and relieve symptoms caused by the cancer, such as pain. The Radiation team plans the treatment by choosing the type, dose and area of radiation therapy to be performed. Radiation therapies include different delivery External radiation

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                             

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

Track 12: Internal Radiation Oncology

Radiation Medicine is a  process in wich they use high-energy radiation, in the form of waves or particles, to destroy cancer cells by damaging their DNA. Because radiation can harm healthy cells, treatment must be carefully planned and precisely conducted to minimize side effects. Radiation therapy may be given before, during, or after other therapies in your treatment plan. It may be used alone or with other treatments to destroy cancer cells, shrink tumors, prevent recurrence and relieve symptoms caused by the cancer, such as pain. The Radiation team plans the treatment by choosing the type, dose and area of radiation therapy to be performed. Internal radiation(these include different radioactive material like seeds, beads, wires or other radioactive substances for the treatment by placing them within the body near the cancer cells. People involved in radiation medicine are Medical Physicist, Radiation Oncologist, Dosimetrist, Radiation Therapist.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                      

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; The Endocrine Society Annual Meeting April 1-4, 2016 Boston, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE

Track 13: Nuclear Medicine

Nuclear medicine imaging uses small amounts of radioactive materials called radiotracers that are typically injected into the blood stream, inhaled or swallowed. The radiotracer travels through the area being examined and gives off energy in the form of gamma rays which are detected by a special camera and a computer to create images of the inside of your body. Nuclear medicine imaging provides unique information that often cannot be obtained using other imaging procedures and offers the potential to identify disease in its earliest stages.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                   

International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; 12th Global Summit on Cancer Therapy September 26-28, 2016 London, UK; 13th Global Summit on Cancer Therapy October 17-19, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; Advances in Medical and Surgical Management of Thyroid Cancer January 15-16, 2016; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA

Track 14: World Cancer Market

Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. Immunotherapies/ biologics are emerging as potential therapies to find the permanent cure for various cancer types. Amongst various biologics, drugs based on monoclonal antibodies (mAbs) have gained significant attention in recent years due to their high efficacy. Global cancer drugs market accounted for $78,238.9 million in 2015, and is forecast to generate revenue of $111,938.4 million by 2020.

Recommended Conferences Cancer ConferencesCancer Meetings Cancer Events                            

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

 

 

14th World Oncologists Annual Conference International Conferences invites all the participants from all over the world to attend the prestigious Scientific Conference on Cancer and Radiation Medicine  during November,28-30, 2016 in San Francisco, USA which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

 

World Oncologists 2016 provide a platform for the multidisciplinary discussion on research, education, and patient management of Cancer malignancy. We summarize the latest major trends and controversies within the field of Cancer oncology and Radiation Practices  including the use of ultrasound, standardization of cytology, role of molecular testing, treatment options for small recurrence including ablation and observation, management of recurrent laryngeal nerve injury, importance of identification of the external branch of the superior laryngeal nerve, role of minimally invasive Cancer surgery, trends in radioactive iodine treatment, advancements in targeted agents, and the importance of personalizing treatment to individual patients.

 

conference Series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With members from around the world focused on learning about Cancer and its advances; this is your best opportunity to reach the largest assemblage of participants from the Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Cancer  are hallmarks of this conference.

Target Audience:

physicians and practicing nurse

Drug Manufacturing Companies

Radiation Therapist

Oncology Societies

Clinical Researchers

Leading world Doctors

Surgical and Medical Oncologists

Young Researchers

Students & Delegates

Business Entrepreneurs

Health Professionals

Related Societies:

American Cancer Society

American Association for cancer research

American Neuroma Association

Cancer Research Institute

National Cancer Society of USA

National Cancer Institute

Cancer Research UK

Association of oncology Social work

The Association for Cancer Surgery (BASO)

Global Initiative against HPV and Cervical Cancer       

Global Lung Cancer Coalition (GLCC)

International Gynecologic Cancer Society

Major Cancer Associations USA

 Oncology society

Anti-Cancer Association

National Cancer Council,

Breast Cancer Welfare Association

Cancer Research Initiatives Foundation

Society of Paediatric Haematology and oncology

 

 

World Cancer Market

Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. Immunotherapies/ biologics are emerging as potential therapies to find the permanent cure for various cancer types. Amongst various biologics, drugs based on monoclonal antibodies (mAbs) have gained significant attention in recent years due to their high efficacy. Global cancer drugs market accounted for $78,238.9 million in 2015, and is forecast to generate revenue of $111,938.4 million by 2020.

The report covers exhaustive analysis on:

·         Market Segments

·         Market Dynamics

·         Market Size

·         Supply & Demand

·         Current Trends/Issues/Challenges

·         Competition & Companies involved

·         Technology

·         Value Chain

Market Segment Review:

Global cancer drugs market by therapeutic modalities is segmented into chemotherapy, Targeted therapy, Immunotherapy, Hormonal therapy and others. Immunotherapy dominates the global market for cancer drugs due to its high efficacy and less side effects. Monoclonal antibodies such as trastuzumab, bevacizumab and rituximab are potential immunotherapeutic agents that have achieved magnanimous sales. The cancer immunotherapy market is primarily driven by huge research investments from multinational companies along with research collaborations for the development of cancer immunetherapeutics. Over the past few years, targeted cancer therapies have gained significant attention due to their tumor cell specific action in protecting healthy cells from the toxic effects of cancer drugs. 

Global cancer drugs market by cancer type is segmented into Blood cancer, Breast cancer, gastrointestinal tract cancer, Prostate cancer, Lung Cancer, Skin Cancer and other cancer. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2015. 

Geographic Review:

Geographically, the Global cancer drugs market segments into North America, Europe, Asia-Pacific and LAMEA. North America dominates the market for cancer drugs as the region houses companies engaged in the development of cancer drugs. Additionally, the disposable incomes of consumers and health insurance cover for life-threatening diseases in North America are very high which increases the affordability of cancer treatment. In recent years, US Food and Drug Administration (USFDA) has taken initiatives to support the growth of cancer drugs market by providing pre-market approval to the drugs, which are in the clinical phase; thus, accelerating the clinical development. 

Competitive Review:

The key players profiled in this report include Amgen Inc., Johnson & Johnson, GlaxoSmithKline, Eli lilly & Co., Roche diagnostics, Novartis AG, Pfizer, Merck & Co., Sanofi, and Celgene Corporation. Roche, Novartis and Celgene are the top three players in Global cancer drugs market with a wide of cancer product portfolio. The three companies contribute to ~60% of the total market share. The immunotherapeutics developed by Roche namely Rituxan, Avastin and Herceptin achieved blockbuster sales in 2013. A majority of the cancer drug manufacturers have adopted collaboration, approval and acquisition as their key developmental strategies to achieve a competitive edge. Moreover, companies are forming strategic alliances to accelerate their clinical developments. These strategies have proved to be effective in helping key players retain their leading positions in the global market.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 28-30, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2 Day 3
Poster Opportunity Closed Click Here to View